Vinpocetine attenuates lipid accumulation and atherosclerosis formation. - Wikidata - wikimedia - TriplyDB

Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

http://www.wikidata.org/entity/Q36928884

about

Vinpocetine inhibits Streptococcus pneumoniae-induced upregulation of mucin MUC5AC expression via induction of MKP-1 phosphatase in the pathogenesis of otitis media Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord.Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathway miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease.Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.An update on vinpocetine: New discoveries and clinical implications.Isoquinoline Alkaloids and Indole Alkaloids Attenuate Aortic Atherosclerosis in Apolipoprotein E Deficient Mice: A Systematic Review and Meta-Analysis.Roles of PDE1 in Pathological Cardiac Remodeling and Dysfunction.Effect of piracetam, vincamine, vinpocetine, and donepezil on oxidative stress and neurodegeneration induced by aluminum chloride in rats

P2860

Q30653282-82F163C0-09FB-4E8C-A3E4-A8F43A12094B Q35590068-ED795D4A-C292-40EA-9A73-92D7B005F1DD Q38825692-24094375-56C1-48DA-BA03-6A30DC450D67 Q39026612-A77DA364-C0BE-447D-92B9-E7E3283838C8 Q40286859-C1099170-C765-4261-AD49-D85B953A7CB4 Q47727950-0A9B7260-E88F-48B2-A878-6DD50811696D Q49567493-05E61291-1103-4457-90FA-CBF99F22364B Q55217000-BA74EAD4-5BA0-4D67-A358-CCFA2E4C9A78 Q55416779-E2AF20EB-FF41-4BAA-893A-4B8A4A63C9C5 Q57729845-EBAA3275-70AA-4A9C-8359-43505B071267

P2860

Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

http://www.wikidata.org/entity/Q36928884

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

@en

type

label

Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

@en

prefLabel

Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

@en

P1433

Q36928884-87276CBA-E13B-476F-862E-1E6FE910DD42

P1476

Q36928884-697B176A-25D6-41F4-9F2B-971F060606C0

P2093

Q36928884-0DCF876D-134C-43D2-A662-4BBFA5BA585F

Q36928884-295EE3EE-9A73-4170-8D0E-4C1F6F2B11D9

Q36928884-AC7D442D-4968-470D-90FF-2C1E3DAC2208

P2860

Q36928884-1A121407-320B-4486-910E-0CB369759AC7

Q36928884-4610CF34-E0F7-4831-8B01-ECE44756E948

Q36928884-4F3210D0-7D04-4EDD-A8CD-6A53F210ED18

Q36928884-53783A8E-8091-48AC-9217-26A3122981B5

Q36928884-5C1E1710-A9D5-4F61-B195-7EA2C1373F85

Q36928884-5CE1A853-38B5-43F7-B7F1-21FCF0173A60

Q36928884-7BFF3C79-B6D3-4A67-ABF6-05B46A6DEE89

Q36928884-7E674BCA-3E6C-4C14-A515-FB338F942969

Q36928884-837A7E9C-533D-4301-B196-11B110CE3414

Q36928884-8D2A905B-74A6-4C59-BCD7-6394CA58C8EC

P304

Q36928884-6A69DD19-B37F-441E-B8BD-E77D4881C85E

P31

Q36928884-0A20A0DD-0B4C-46EB-B5D0-54DA3C029A04

P356

Q36928884-3516141B-AD89-4EA4-9DB4-B8BAEB87E9BD

P407

Q36928884-DFD0FAA0-330F-4065-8909-4578E9E28EEA

P433

Q36928884-E1C33D0E-C91C-402F-9555-B3041B6FDA77

P478

Q36928884-BE185560-943F-4C9E-B6F8-F6A9BC1FEBDF

P577

Q36928884-B9C7B08D-0EFB-4F7A-81F9-86F9DA7CF25A

P5875

Q36928884-29861740-456E-4A6B-8DA7-9298DE9AC453

P698

Q36928884-A9125447-340C-4160-8803-805A11AFFF63

P921

Q36928884-1D48B8CA-50AB-429F-8D17-6B78C12E0454

P932

Q36928884-30ECF82E-5073-43E4-B083-0E259053749C

P356

J.BBRC.2013.03.092

P1433

Biochemical and Biophysical Research Communications

P1476

Vinpocetine attenuates lipid accumulation and atherosclerosis formation.

@en

P2093

Chen Yan

http://www.w3.org/2001/XMLSchema#string

Jian-Dong Li

http://www.w3.org/2001/XMLSchema#string

Yujun Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism

Inflammation in atherosclerosis

The pathogenesis of atherosclerosis: a perspective for the 1990s

Mouse models of arteriosclerosis: from arterial injuries to vascular grafts.

Hypertension and endothelial dysfunction in apolipoprotein E knockout mice.

Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.

Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.

Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice.

The discovery of LOX-1, its ligands and clinical significance.

P304

439-443

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2013.03.092

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

434

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236179892

http://www.w3.org/2001/XMLSchema#string

P698

23583194

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3682500

http://www.w3.org/2001/XMLSchema#string